Stoke Therapeutics, Inc. (STOK)

NASDAQ: STOK · Real-Time Price · USD

32.40

+0.27 (0.84%)

Aug 18, 2026, 1:12 PM EDT - Market open

Stoke Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	110	84.22	127.98	191.44	113.56	144.9
Short-Term Investments	182.81	200.45	88.92	9.95	116.04	74.92
Cash & Short-Term Investments	292.82	284.67	216.9	201.39	229.6	219.81
Cash Growth	18.21%	31.25%	7.70%	-12.28%	4.45%	-23.49%
Accounts Receivable	7.18	5.94	1.67	-	-	-
Other Receivables	1.54	1.97	0.7	0.06	0.59	0.13
Receivables	8.72	7.91	2.37	0.06	0.59	0.13
Prepaid Expenses	14.69	8.74	11.12	11.32	10.93	6.94
Restricted Cash	-	0.49	0.08	-	-	-
Other Current Assets	6.31	3.9	2.3	2.56	2.96	2.33
Total Current Assets	322.54	305.7	232.76	215.34	244.07	229.22
Property, Plant & Equipment	6.7	6.25	8.25	12.43	11.43	9.08
Long-Term Investments	61.5	106.26	29.82	-	-	-
Other Long-Term Assets	3.23	0.23	0.72	0.57	0.57	0.57
Total Assets	393.97	418.43	271.56	228.34	256.07	238.87

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	4.79	4.94	2.5	1.7	0.77	2.39
Accrued Expenses	25.15	36.97	15.49	10.9	12.88	12.71
Current Portion of Leases	1.85	3.01	2.32	2.06	2.36	1.51
Current Unearned Revenue	8.52	11.9	18.99	15.31	14.88	-
Other Current Liabilities	1.62	1.06	0.75	0.86	0.51	0.54
Total Current Liabilities	41.93	57.88	40.06	30.82	31.39	17.14
Long-Term Leases	0.84	1.14	2.45	4.77	2.72	3.53
Long-Term Unearned Revenue	5.65	6.96	-	33.07	36.86	-
Other Long-Term Liabilities	-	-	0.03	0.11	0.25	0.42
Total Liabilities	48.42	65.98	42.53	68.78	71.22	21.09

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.01	0.01	0.01	0.01	0	0
Additional Paid-In Capital	955.42	849.62	720	561.43	483.17	414.02
Retained Earnings	-609.34	-497.72	-490.83	-401.85	-297.15	-196.08
Comprehensive Income & Other	-0.54	0.54	-0.15	-0.02	-1.18	-0.17
Total Common Equity	345.55	352.46	229.02	159.57	184.85	217.78
Shareholders' Equity	345.55	352.46	229.02	159.57	184.85	217.78
Total Liabilities & Equity	393.97	418.43	271.56	228.34	256.07	238.87

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	2.68	4.15	4.77	6.84	5.08	5.04
Net Cash (Debt)	351.64	386.78	241.95	194.56	224.52	214.77
Net Cash Growth	0.06%	59.86%	24.36%	-13.34%	4.54%	-24.95%
Net Cash Per Share	5.63	6.53	4.48	4.42	5.77	5.85
Filing Date Shares Outstanding	64.53	59.15	54.08	46.3	44.15	37.36
Total Common Shares Outstanding	62.4	58.92	54.03	45.92	39.44	36.9
Working Capital	280.61	247.83	192.7	184.52	212.68	212.08
Book Value Per Share	5.54	5.98	4.24	3.47	4.69	5.90
Tangible Book Value	345.55	352.46	229.02	159.57	184.85	217.78
Tangible Book Value Per Share	5.54	5.98	4.24	3.47	4.69	5.90
Machinery	-	10.46	10.31	10.14	8.57	4.93
Construction In Progress	-	0.62	0.12	0.07	0.45	1.61
Leasehold Improvements	-	2.21	2.33	2.29	1.87	0.26

SEC Filings: 10-K · 10-Q